Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
4-3-1|X-Zr 0,n/a|Sequence:1, Age:84,Type:none (controls),Quantity:0,Unit:unit code not relevant,Application:not applicable or not supplied, Remarks:Control|120 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 6, 12 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
4-3-2|Xsh-Zr 0,n/a|Sequence:1, Age:84,Type:shamexposed,Quantity:0,Unit:unit code not relevant,Application:not applicable or not supplied, Remarks:sham irradiated|120 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 6, 12 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
4-3-3|Zr,n/a|Sequence:1, Age:84,Type:ZrO2 (Zirconotrast colloid),Quantity:120,Unit:microliters,Application:Injection, intravenous, Remarks:13% w/v|120 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 6, 12 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
4-3-4|N-Gy 10,n/a|Sequence:1, Age:84,Type:neutrons>10 MeV,Quantity:10,Unit:grays,Application:External exposure, Remarks:50 fract.at 2w interval|120 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 6, 12 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
4-3-5|Zr+N-Gy 10,n/a|Sequence:1, Age:84,Type:neutrons>10 MeV,Quantity:10,Unit:grays,Application:External exposure, Remarks:50 fract.at 2w interval|120 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 6, 12 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
4-3-5|Zr+N-Gy 10,n/a|Sequence:2, Age:84,Type:ZrO2 (Zirconotrast colloid),Quantity:120,Unit:microliters,Application:Injection, intravenous, Remarks:13% w/v|120 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Serial sacrifice 6, 12 months after exposure and lifespan microscopic/macroscopic pathology|No information on individuals available for this study
		
